Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04077281
Other study ID # CIHR#419518
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2023
Est. completion date December 2024

Study information

Verified date November 2023
Source St. Joseph's Healthcare Hamilton
Contact Anne Holbrook
Phone 905-522-1155
Email holbrook@mcmaster.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Medication safety is a crucial health issue for every older Canadian since many of the medications causing serious harm are those which also have life-saving or important symptom-relieving benefits. Very few specialists can accurately advise seniors which medications provide more benefit than harm for them personally, and make changes safely as this requires a very large breadth and depth of knowledge about the patient, the conditions they have and their therapies. Now that telemedicine is compatible with smart phones, this extends the ability of scarce specialists to 'see' any patient in Canada in a way that is more convenient for the patient and may be less expensive than current care. This project will find out whether a unique Clinical Pharmacology specialist team in Hamilton, Ontario can improve medication safety (stop medications no longer needed, reduce doses where appropriate, change to safer medications) for a high risk group of older hospitalized Canadians taking many medications. The hospital where this pilot study will take place was the first to install the world's leading electronic health record and set it up to facilitate and support high quality research. Patients who volunteer will be assigned to their usual care, or to the intervention which is the Clinical Pharmacology specialist team approach starting in hospital and following up with the patient at home using telemedicine and detailed communication with them, their caregiver, family physician, community pharmacist and other specialists. The investigators will study whether the intervention is effective and cost-effective at reducing harmful medication burden, reducing the need to return to hospital, or improving the patient's ratings of their care coordination. The results will determine whether a subsequent large trial is worthwhile.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date December 2024
Est. primary completion date November 19, 2024
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Adults over the age of 65 years. - Admitted to Medicine or Surgery services for more than 2 days. - High cost users (defined as): - Have at least one other hospitalization within the previous year. - Taking 5 or more chronic medications including at least one TRIIM-Med. - Provide informed consent. Exclusion Criteria: - Patients with "do not approach status". - Patient or Caregiver not fluent in English. - Patients who do not provide informed consent. - Patients admitted for < 2 days. - Patients < 65 years of age. - Not a high cost user (as defined above).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Medication Coordinated care
Clinical Pharmacology & Toxicology consult CPT team completes detailed circle of care communication Telemedicine followup by CPT team (approximately 48 hrs post-discharge & 1 week to1 month post-discharge)

Locations

Country Name City State
Canada St. Joseph's Healthcare Hamilton Hamilton Ontario

Sponsors (2)

Lead Sponsor Collaborator
St. Joseph's Healthcare Hamilton Canadian Institutes of Health Research (CIHR)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility Outcome: Recruitment rate for eligible patients. The main trial will be considered feasible if we are able to recruit at least 50% of eligible patients in this pilot. Through the study completion, an average of 2 years
Primary Clinical Outcome: The number of TRIIM-Meds successfully deprescribed. The number of TRIIM-Meds successfully deprescribed (dose reduction or discontinued) at 2 months post-hospital discharge, aiming to be able to detect a mean difference of 0.5. 2 months post discharge
Secondary Feasibility Outcomes of CPT consultation volume capacity and potential to apply the intervention entirely through telemedicine. This will be measured based on the number of successfully enrolled patients, and the number of patients that will entirely undergo the intervention through telemedicine. Through the study completion, an average of 2 years
Secondary Feasibility Outcomes of patient retention rate. This will be measured by looking at the number of patients enrolled, the number of patients that dropped out, and the number of patients that completed the study. Through the study completion, an average of 2 years
Secondary Feasibility Outcomes of likelihood of the intervention proving cost-effective. This will be measured using Healthcare resource utilization questionnaire, which will determine whether the intervention reduced healthcare costs compared to the control group. Through the study completion, an average of 2 years
Secondary Patient-important outcomes: Participant ratings of coordination and continuity of transitions in care. This outcome will be measured using the Coordination and Continuity of Care Questionnaire (CCCQ). Which is a questionnaire we adapted from the brief prepared questionnaire (B-PREPARED) and the three-question care transitions measure questionnaire (CTM-3). 2 months post discharge
Secondary Patient-important outcomes: Health related quality of life: EQ-5D-5L This outcome will be measured using the EuroQol five-dimensional, five-level descriptive system (EQ-5D-5L) that asks patients to self-assess their own health quality related quality of life. Whereas a scoring metric is used to assess the overall health related quality of life based on the answers to the questions. The questionnaire scale considers 1 as the best possible health and 5 as the worst health possible. 2 months post discharge
See also
  Status Clinical Trial Phase
Completed NCT06454071 - Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients Phase 2
Completed NCT03297567 - Physical Therapy Guidelines For Hospitalized Elderly N/A
Completed NCT00404118 - Senior Coordinated Referral Study N/A
Not yet recruiting NCT04419753 - The Role of Attention Focus Walking Training in Older Adults. N/A
Completed NCT03138265 - HIT Training in the Frail Elderly. N/A
Completed NCT02598882 - Virtual Reality as a Tool for Rehabilitation on Elderly People N/A
Completed NCT02598115 - Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older N/A
Completed NCT05447533 - Clostridioides Difficile and Frailty N/A
Completed NCT04127539 - Evaluation of Strong & Steady - Fall Preventive Group Exercise Program N/A
Completed NCT05586828 - A Single-center Retrospective Cohort Study to Explore the Prognostic Significance of CONUT in Elderly CAD Patients With HFpEFand Compare CONUT With Other Objective Nutritional Indices.
Completed NCT04536324 - The Absorption Rate of Subcutaneous Infused Fluid
Not yet recruiting NCT04516174 - Effect of Transversus Abdominis Plane Block Combined With Dexmedetomidine Infusion on the Prognosis in Elderly Patients Undergoing Abdominal Surgery N/A
Completed NCT02918058 - Reducing Post-discharge Potentially Inappropriate Medications Among Older Adults N/A
Suspended NCT05107947 - Light in Frail Elderly - the Effect of a Dynamic Light for Sleep and Circadian Rhythm N/A
Completed NCT03336177 - Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients.
Completed NCT06095661 - Virtual Reality as a Postoperative Pain Management Adjunct in Older Adults: An Acceptability and Feasibility Study N/A
Completed NCT04715971 - Urinary Retention on an Acute Geriatric Hospitalisation Unit.
Recruiting NCT04327115 - Study of an Physical Exercise Program on Older People of 75 Years Old and More, Hospitalized in Geriatric Short Stay N/A
Recruiting NCT04128410 - A Study on Central Transport Characteristics of Flurbiprofen Axetil in Elderly Patients
Completed NCT02253199 - The Effect of Age on the Median Effective Dose (ED50) of Intranasal Dexmedetomidine for Rescue Sedation Following Failed Sedation With Oral Chloral Hydrate During Magnetic Resonance Imaging Phase 4